The global severe hypertriglyceridemia treatment market is experiencing robust growth, with a market value of USD 702.95 million in 2023 and an impressive forecasted growth to USD 2,675.37 million by 2033. This growth trajectory represents a compound annual growth rate (CAGR) of 14.3% from 2023 to 2033. The market’s expansion can be attributed to the …